Bonastre, Julia <br/><br/>
Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?  [electronic resource] 

 -  Health policy (Amsterdam, Netherlands)  Jun 2014 
 - 162-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6054 
<br/><br/><label>Standard No.: </label>10.1016/j.healthpol.2013.11.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--economics<br/>Breast Neoplasms--drug therapy<br/>Diagnosis-Related Groups--economics<br/>Diffusion of Innovation<br/>Drug Costs--statistics & numerical data<br/>Female<br/>France--epidemiology<br/>Health Services Accessibility--economics<br/>Hospitals, Private--economics<br/>Hospitals, Public--economics<br/>Humans<br/>Male<br/>Models, Statistical<br/>Neoplasms--drug therapy